Potential risks and benefits of prenatal selective serotonin reuptake inhibitor medications for maternal mental health and child development
- DOI
- 10.1038/s44220-025-00480-w
- Published
- 2025-09-04
- Container
- Nature Mental Health
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s44220-025-00480-w,
title = {Potential risks and benefits of prenatal selective serotonin reuptake inhibitor medications for maternal mental health and child development},
author = {Jodi Pawluski and Tim F. Oberlander},
year = {2025},
journal = {Nature Mental Health},
doi = {10.1038/s44220-025-00480-w},
url = {https://doi.org/10.1038/s44220-025-00480-w}
}RIS
TY - JOUR TI - Potential risks and benefits of prenatal selective serotonin reuptake inhibitor medications for maternal mental health and child development AU - Jodi Pawluski AU - Tim F. Oberlander PY - 2025 JO - Nature Mental Health DO - 10.1038/s44220-025-00480-w UR - https://doi.org/10.1038/s44220-025-00480-w ER -
APA
Pawluski, J., & Oberlander, T. F. (2025). Potential risks and benefits of prenatal selective serotonin reuptake inhibitor medications for maternal mental health and child development. Nature Mental Health. https://doi.org/10.1038/s44220-025-00480-w
Source records
- crossref · retrieved 2026-09-26T19:59:51.849Z